Skip to main content

Advertisement

Table 6 Characteristics of discordant subjects at risk of false positive LSM or false negative FibroTest

From: Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

Characteristics Discordant not reinvestigated Discordant reinvestigated
Number of subjects 30 18
Age >60 years 14/30 (47%) 4/18 (22%)
Male (%) 21 (70%) 12 (67%)
Fatty liver risk factor (Alcohol or metabolic)   
Self-declared alcohol consumption at risk* 8/30 (27%) 2/18 (11%)
Elevated Carbohydrate Deficient Transferin (>1.6%) 9/30 (30%) 12/18 (67%) (P = 0.01)
Alcohol at risk (either consumption or CDT) 16/30 (53%) 13/18 (72%)
BMI >= 27.0 10/30 (33%) 4/18 (22%)
Metabolic factor of ATP-III classification (at least one)   
Glucose >= 6.1 mmol/L or diabetes treatment 7/30 (23%) 2/18 (11%)
Central obesity waist >102 male >88 female 7/30 (23%) 2/18 (11%)
Triglycerides >= 1.7 mmol/L or fibrate treatment 8/30 (27%) 2/17 (12%)
Hypertension or treatment 12/30 (40%) 2/18 (11%) (P = 0.05)
HDL-cholesterol <1.03 mmol/L male <1.29 mmol/L female 2/30 (7%) 1/18 (6%)
Steatosis predicted by SteatoTest 7/30 (23%) 3/17 (18%)
HCV antibody positive 0/30 (0%) 0/18 (0%)
HIV antibody positive 0/30 (0%) 0/18 (0%)
HBsAg antigen positive 1/30 (3%) 0/18 (0%)
  1. *More than one drink per day for female and more than two drinks per day for male